Southland Equity Partners LLC Has $770,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Southland Equity Partners LLC increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 51.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,741 shares of the company's stock after buying an additional 1,618 shares during the quarter. Southland Equity Partners LLC's holdings in Clorox were worth $770,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC bought a new position in Clorox during the 3rd quarter valued at $54,000. AQR Capital Management LLC boosted its stake in shares of Clorox by 8.6% during the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock worth $39,121,000 after acquiring an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC boosted its stake in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock worth $31,266,000 after acquiring an additional 10,149 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in shares of Clorox by 60.5% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company's stock worth $3,244,000 after acquiring an additional 8,957 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its stake in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CLX shares. Wells Fargo & Company raised Clorox from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and increased their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and increased their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. increased their target price on Clorox from $167.00 to $171.00 and gave the company a "neutral" rating in a report on Thursday, January 16th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $156.54.

Clorox Stock Down 1.1 %

NYSE CLX traded down $1.71 during trading on Friday, hitting $159.12. 946,101 shares of the company traded hands, compared to its average volume of 992,551. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The business has a fifty day simple moving average of $163.83 and a 200 day simple moving average of $157.13. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $19.70 billion, a P/E ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $0.49 earnings per share. The business's revenue was up 27.0% compared to the same quarter last year. As a group, sell-side analysts predict that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is currently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.